Jody Elizabeth Navitsky, MD
Pediatrics · Hartford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Navitsky’s office at (608) 547-0970 to ask if they take your plan before you enroll.
Medicaid work
$141,906 in 2024
Medicaid paid $141,906 for 3,455 billed services this clinician did in 2024, up to 161 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 935 | $141,906 |
| TOBACCO USE ASSESSED | 67 | $0 |
| Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD) | 148 | $0 |
| TOBACCO USE TXMNT COUNSELING | 67 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 287 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 81 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 12 | $0 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 38 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 164 | $0 |
| Pure tone audiometry (threshold); air only | 195 | $0 |
| Developmental screening | 166 | $0 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 351 | $0 |
| 2024 | 3,455 | 17 | 161 | $141,906 |
| 2023 | 5,582 | 24 | 173 | $257,641 |
| 2022 | 6,876 | 21 | 222 | $345,075 |
| 2021 | 6,348 | 20 | 231 | $321,928 |
| 2020 | 6,892 | 20 | 221 | $363,190 |
| 2019 | 5,549 | 24 | 174 | $262,763 |
| 2018 | 6,896 | 30 | 214 | $286,138 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,575 | $257,641 |
| TOBACCO USE ASSESSED | 59 | $0 |
| Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD) | 216 | $0 |
| TOBACCO USE TXMNT COUNSELING | 57 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 604 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 201 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 20 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 12 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 30 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 43 | $0 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 102 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 335 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 2,156 | $345,075 |
| TOBACCO USE ASSESSED | 33 | $0 |
| Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD) | 234 | $0 |
| TOBACCO USE TXMNT COUNSELING | 30 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 819 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 220 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 26 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 68 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 69 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 540 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 14 | $0 |
| Pure tone audiometry (threshold); air only | 307 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,032 | $321,791 |
| Short return visit (20+ min) | 722 | $138 |
| Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD) | 192 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 700 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 244 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 12 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 87 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 76 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 473 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 61 | $0 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 13 | $0 |
| Pure tone audiometry (threshold); air only | 289 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,483 | $363,044 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 792 | $146 |
| Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD) | 92 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 272 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 12 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 78 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 66 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 526 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 31 | $0 |
| Pure tone audiometry (threshold); air only | 189 | $0 |
| IMMUNOTHERAPY ONE INJECTION | 571 | $0 |
| Developmental screening | 273 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,744 | $262,763 |
| Puncture of skin for collection of blood sample | 15 | $0 |
| HEMOGLOBIN | 15 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 827 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 316 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 40 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 135 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 142 | $0 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 16 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 443 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 105 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,905 | $286,138 |
| Puncture of skin for collection of blood sample | 17 | $0 |
| HEMOGLOBIN | 131 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 788 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 343 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 117 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 105 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 41 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 150 | $0 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 46 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 401 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 15 | $0 |
Money from drug and device companies
$240 in 2025
| 2025 | 8 | 13 | None | $240 |
| 2024 | 6 | 11 | None | $214 |
| 2023 | 6 | 9 | None | $186 |
| 2022 | 3 | 6 | None | $105 |
| 2021 | 1 | 4 | None | $83 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 4 | 14 | None | $176 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $78 | 3 payments
|
| Kowa Pharmaceuticals America | Zoryve | $31 | 2 payments
|
| Cranial Technologies | Doc Band | $30 | 3 payments
|
| Organon | None | $28 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $23 | 1 payment
|
| Seqirus USA | Flucelvax | $19 | 1 payment
|
See all 13 published payments
| Xeris Pharmaceuticals | Meals · 2025-09-18 | Gvoke Hypopen | $23 |
| Organon | Meals · 2025-09-15 | None | $28 |
| Merck Sharp & Dohme | Meals · 2025-08-21 | Proquad | $14 |
| Pfizer | Meals · 2025-08-20 | Prevnar 20 | $30 |
| Kowa Pharmaceuticals America | Meals · 2025-08-13 | Zoryve | $15 |
| Seqirus USA | Meals · 2025-06-11 | Flucelvax | $19 |
| Kowa Pharmaceuticals America | Meals · 2025-06-10 | Zoryve | $17 |
| Pfizer | Meals · 2025-04-29 | Prevnar 20 | $30 |
| Pfizer | Meals · 2025-03-24 | Prevnar 20 | $17 |
| Tris Pharma | Meals · 2025-03-18 | Onyda Xr | $17 |
| Cranial Technologies | Meals · 2025-02-14 | Doc Band | $15 |
| Cranial Technologies | Meals · 2025-01-24 | Doc Band | $15 |
| Cranial Technologies | Meals · 2025-01-24 | Doc Band | $1 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $214
| Pfizer | Trumenba | $60 | 3 payments
|
| GlaxoSmithKline | Bexsero | $46 | 2 payments
|
| Vertical Pharmaceuticals | Relexxii | $37 | 2 payments
|
| Merck Sharp & Dohme | Gardasil | $33 | 2 payments
|
| Sanofi Pasteur | Beyfortus | $21 | 1 payment
|
| Cranial Technologies | Doc Band | $17 | 1 payment
|
2023: $186
| Seqirus USA | Flucelvax Quadrivalent | $57 | 2 payments
|
| Cranial Technologies | Doc Band | $48 | 3 payments
|
| Sanofi Pasteur | Beyfortus | $26 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Flumist Quadrivalent | $20 | 1 payment
|
| GlaxoSmithKline | Bexsero | $20 | 1 payment
|
| Merck Sharp & Dohme | Vaqta | $15 | 1 payment
|
2022: $105
| Pfizer | Prevnar 13 | $53 | 3 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $29 | 2 payments
|
| GlaxoSmithKline | Bexsero | $23 | 1 payment
|
2021: $83
| Pfizer | Eucrisa | $83 | 4 payments
|
2020: $18
| Pfizer | Prevnar 13 | $18 | 1 payment
|
2019: $176
| Pfizer | Eucrisa | $123 | 10 payments
|
| Cranial Technologies | Doc Band | $28 | 2 payments
|
| Sanofi Pasteur | Pentacel | $12 | 1 payment
|
| Genentech USA | Xolair | $12 | 1 payment
|
Professional record
- NPI
- 1609812080
- Licence
- CT 043718
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A929500
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 80 Phoenix Ave, Ste 201, Waterbury, CT, 06702
- NPI first listed
- 2006-06-22
- NPI last updated
- 2018-07-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128